[Applying root cause analysis to promote the medication safety of continuous drug infusions for infants]

Chia-Hui Chien1, Ya-Ling Yang2, Guei-Ling Fann1

  • 1Department of Nursing, National Taiwan University Hospital, Taiwan, ROC.

Abstract

Insights

Implementing standardized procedures and enhanced training significantly improved medication administration safety in the infant intensive care unit, achieving a 99% completion rate and eliminating adverse events.

Area of Science:

  • Pediatric Patient Safety
  • Medication Administration Protocols
  • Healthcare Quality Improvement

Context:

  • An adverse medication event due to a dosage error in continuous drug infusion occurred in a pediatric intensive care unit.
  • Root cause analysis identified issues in prescription, procedure completion, verification, transcription, and nursing knowledge.

Purpose:

  • To achieve a 100% completion rate for nurse-administered continuous intravenous medications.
  • To eliminate adverse medication events in the pediatric intensive care unit.

Summary:

  • Implemented strategies included simplifying prescription verification, standardizing administration steps, developing dosage criteria, and establishing a double-check mechanism for high-risk medications.
  • Provided continuous educational programs for nurses on effective drug administration.
  • Achieved a 99% completion rate for medication administration steps and a 96% compliance rate for pediatrician's orders.

Impact:

  • Established a systemic drug administration mechanism enhancing healthcare team communication and cooperation.
  • Significantly improved medication safety and quality for infant patients.
  • Prevented further adverse medication events post-intervention.

Related Concept Videos

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions01:24

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions

Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
423
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
1.0K
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
386
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
408
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
116
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
967